Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder.

scientific article published on August 2017

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2017.32.8.1327
P932PMC publication ID5494333
P698PubMed publication ID28665070

P50authorJin Wook KimQ56987070
Inho ChangQ73725392
Tae-Jin LeeQ87321893
Subin JinQ88423239
Young Mi WhangQ88423242
Ha Jeong KimQ88423244
Soon Auck HongQ88423246
P2093author name stringJin Wook Kim
Young Mi Whang
In Ho Chang
Tae Jin Lee
Ha Jeong Kim
Soon Auck Hong
Subin Jin
P2860cites workPhase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkersQ83802452
Annexins: from structure to functionQ29616171
Annexins: linking Ca2+ signalling to membrane dynamicsQ29619942
Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancerQ33354798
Phase II study of everolimus in metastatic urothelial cancerQ33606604
Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.Q33922437
Predicting recurrence and progression of non-muscle-invasive bladder cancer in Korean patients: a comparison of the EORTC and CUETO modelsQ34346848
P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor modelQ35089340
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerQ35620687
Mammalian target of rapamycin inhibition as therapy for hematologic malignanciesQ35653049
Molecular mechanisms of resistance and toxicity associated with platinating agentsQ35758048
Annexins and diseaseQ35874289
Role of copper transporters in the uptake and efflux of platinum containing drugsQ36317284
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?Q36944025
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesQ37195644
A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomasQ37267313
Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancerQ39062692
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue8
P304page(s)1327-1336
P577publication date2017-08-01
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titleIdentification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
P478volume32

Reverse relations

cites work (P2860)
Q55440708FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Q48272655Letter to the Editor: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer.

Search more.